SYNAPSE BIOMEDICAL INC — Form D
SYNAPSE BIOMEDICAL INC of OBERLIN, OH, a company, filed a Form D exempt-offering notice with the SEC on 2022-12-20. The offering totals $810K. Industry: Biotechnology.
Offering
- Filed: 2022-12-20
- Form: D
- Accession: 0001273829-22-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $810K
- Remaining: $810K
- Minimum investment: $2K
- Security types: equity
- Revenue range: $5,000,001 - $25,000,000
- SEC file number: 021-468055
Issuer
- Name: SYNAPSE BIOMEDICAL INC
- CIK: 0001273829
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 300 ARTINO STREET, OBERLIN, OH, 44074
- Phone: 440-774-2488
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Moustapha P Diop | Director | Oberlin, OH |
| Anthony R Ignagni | Director | Oberlin, OH |
| John P Krystowski | Director | Oberlin, OH |
| Kiyotaka P Mori | Director | Oberlin, OH |
| Raymond P Onders | Director | Oberlin, OH |
| Moustapha P Diop | Executive Officer | Oberlin, OH |
| Anthony R Ignagni | Executive Officer | Oberlin, OH |
| Edgar G Engleman | Director | Pleasanton, CA |
| Sungho G Cho | Director | Oberlin, OH |
| Louis G Tabickman | Director | Oberlin, OH |
Other filings by this issuer (1)
More